Sionna Therapeutics, Inc.
SION
$12.04
-$0.10-0.82%
NASDAQ
| 12/31/2024 | |||||
|---|---|---|---|---|---|
| Revenue | -- | ||||
| Total Other Revenue | -- | ||||
| Total Revenue | -- | ||||
| Cost of Revenue | -- | ||||
| Gross Profit | -- | ||||
| SG&A Expenses | 43.44% | ||||
| Depreciation & Amortization | -- | ||||
| Other Operating Expenses | -- | ||||
| Total Operating Expenses | 43.97% | ||||
| Operating Income | -43.97% | ||||
| Income Before Tax | -33.45% | ||||
| Income Tax Expenses | -- | ||||
| Earnings from Continuing Operations | -33.45% | ||||
| Earnings from Discontinued Operations | -- | ||||
| Extraordinary Item & Accounting Change | -- | ||||
| Minority Interest in Earnings | -- | ||||
| Net Income | -33.45% | ||||
| EBIT | -43.97% | ||||
| EBITDA | -44.49% | ||||
| EPS Basic | 13.82% | ||||
| Normalized Basic EPS | 13.82% | ||||
| EPS Diluted | 13.82% | ||||
| Normalized Diluted EPS | 13.82% | ||||
| Average Basic Shares Outstanding | 54.85% | ||||
| Average Diluted Shares Outstanding | 54.85% | ||||
| Dividend Per Share | -- | ||||
| Payout Ratio | -- | ||||